Table 2 Clinicopathological features of 40 cases for validation purpose
Sample no. | Group | Age | Gender | Virus infection status | Child-Pugh classification | Adjacent liver tissue | AFP (ng/ml) | TNM stagea | Tumor number | Tumor size (cm) | Differentiationb | Portal vein invasion | Intrahepatic metastasis | Duration of recurrence (year) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
41 | S | 47 | M | HBV | A | CH | 242 | 3B | Multiple | 11.50 | Mod | Presence | Presence | 0.28 |
42 | S | 37 | F | HBV | A | CH | 102,490 | 3A | Multiple | 6.50 | Por | Presence | Absence | 1.30 |
43 | S | 65 | M | None | A | CH | 3,104,000 | 4A | Single | 9.80 | Por | Presence | Absence | 0.34 |
44 | S | 55 | M | HBV | A | CH | 23.2 | 2 | Single | 6.70 | Mod | Presence | Presence | 0.43 |
45 | S | 57 | M | HCV | A | CH | 4718 | 2 | Single | 4.50 | Por | Presence | Presence | 0.43 |
46 | S | 52 | M | HCV | A | LC | 25 | 2 | Single | 5.80 | Mod | Presence | Presence | 1.05 |
47 | S | 62 | M | HBV | A | CH | 62 | 2 | Single | 7.00 | Mod | Presence | Absence | 0.41 |
48 | S | 79 | M | HCV | A | CH | 134 | 3A | Multiple | 5.00 | Por | Presence | Presence | 0.70 |
49 | S | 67 | M | HCV | A | CH | 18.7 | 2 | Multiple | 4.00 | Mod | Presence | Absence | 0.61 |
50 | S | 66 | M | HCV | A | CH | 2970 | 2 | Multiple | 3.50 | Por | Presence | Presence | 0.58 |
51 | L | 53 | M | None | B | LC | 43.5 | 1 | Single | 3.50 | Mod | Absence | Absence | 2.98 |
52 | L | 71 | M | None | A | Normal | 2.7 | 1 | Single | 3.50 | Well | Absence | Absence | 3.45 |
53 | L | 58 | M | None | A | Normal | 7.5 | 1 | Single | 5.80 | Mod | Absence | Absence | 8.14 |
54 | L | 61 | M | HBV | A | CH | 6.4 | 1 | Single | 2.70 | Well | Absence | Absence | 5.37 |
55 | L | 78 | M | HCV | A | CH | 8.4 | 1 | Single | 2.70 | Mod | Absence | Absence | 5.42 |
56 | L | 60 | M | HBV | A | CH | 7.2 | 1 | Single | 2.60 | Mod | Absence | Absence | 2.71 |
57 | L | 64 | F | HCV | A | LC | 9.9 | 1 | Single | 3.60 | Mod | Absence | Absence | 2.23 |
58 | L | 64 | M | HBV | A | CH | 16.9 | 1 | Single | 3.90 | Mod | Absence | Absence | 4.61 |
59 | L | 72 | M | HCV | B | CH | 103.7 | 1 | Single | 7.40 | Mod | Absence | Absence | 3.72 |
60 | L | 74 | M | None | A | Normal | 4.2 | 1 | Single | 3.50 | Mod | Absence | Absence | 4.28 |
61 | A | 75 | M | HCV | – | CH | – | – | – | – | – | – | – | – |
62 | A | 65 | F | HBV | – | LC | – | – | – | – | – | – | – | – |
63 | A | 70 | M | None | – | Normal | – | – | – | – | – | – | – | – |
64 | A | 63 | F | HBV | – | LC | – | – | – | – | – | – | – | – |
65 | A | 85 | M | HCV | – | CH | – | – | – | – | – | – | – | – |
66 | A | 41 | M | HBV | – | CH | – | – | – | – | – | – | – | – |
67 | A | 58 | M | HCV | – | CH | – | – | – | – | – | – | – | – |
68 | A | 58 | M | HBV | – | CH | – | – | – | – | – | – | – | – |
69 | A | 73 | M | None | – | CH | – | – | – | – | – | – | – | – |
70 | A | 74 | M | None | – | Normal | – | – | – | – | – | – | – | – |
71 | N | 66 | F | None | – | Normal | – | – | – | – | – | – | – | – |
72 | N | 69 | M | None | – | Normal | – | – | – | – | – | – | – | – |
73 | N | 60 | M | None | – | Normal | – | – | – | – | – | – | – | – |
74 | N | 73 | M | None | – | Normal | – | – | – | – | – | – | – | – |
75 | N | 63 | M | None | – | Normal | – | – | – | – | – | – | – | – |
76 | N | 59 | M | None | – | Normal | – | – | – | – | – | – | – | – |
77 | N | 65 | M | None | – | Normal | – | – | – | – | – | – | – | – |
78 | N | 47 | F | None | – | Normal | – | – | – | – | – | – | – | – |
79 | N | 68 | F | None | – | Normal | – | – | – | – | – | – | – | – |
80 | N | 71 | M | None | – | Normal | – | – | – | – | – | – | – | – |